Compositions and methods for the treatment of primary biliary cholangitis
Grant
US12589086B2
Kind: B2
Mar 31, 2026
Assignee
Genfit
Inventors
Pascal Birman, Alice Roudot, David Magrez, Benoit Noel
Abstract
The invention relates to a pharmaceutical composition comprising elafibranor or a pharmaceutically acceptable salt thereof, for use to treat primary biliary cholangitis (PBC) in a subject intolerant to ursodeoxycholic acid (UDCA).
CPC Classifications
A61K 31/192
A61P 1/16
Filing Date
2021-08-25
Application No.
18017591
Claims
9